924300-31-2

Basic information

• Product Name: 4-(benzyloxy)-3,5-dimethylbenzonitrile
• Synonyms: 4-(benzyloxy)-3,5-dimethylbenzonitrile
• CAS NO: 924300-31-2
• Molecular Weight: 237.301
• Mol File: 924300-31-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 4-(benzyloxy)-3,5-dimethylbenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(benzyloxy)-3,5-dimethylbenzonitrile(924300-31-2)
• EPA Substance Registry System: 4-(benzyloxy)-3,5-dimethylbenzonitrile(924300-31-2)

Safety Data

• Hazardous Substances Data: 924300-31-2(Hazardous Substances Data)

Upstream product

• 613-90-1 benzoyl cyanide 
• 168196-87-0 2-benzyloxy-5-bromo-1,3-dimethylbenzene 
• 4198-90-7 3,5-dimethyl-4-hydroxybenzonitrile 
• 100-39-0 benzyl bromide 

Downstream Products

• 1044870-32-7 7-(4-hydroxy-3,5-dimethylphenyl)-2,4-dimethoxy-1,6-naphthyridin-5(6H)-one 
• 1044870-75-8 3-(4-hydroxy-3,5-dimethylphenyl)-6,8-dimethoxy-7-(morpholinomethyl)isoquinoline-1(2H)-one 
• 1044870-33-8 7-(4-hydroxy-3,5-dimethylphenyl)-2,4-dimethoxy-1,6-naphthyridin-5(6H)-one hydrochloride 
• 1044871-08-0 7-(4-hydroxy-3,5-dimethylphenyl)-2,4-diisopropoxy-1,6-naphthyridin-5(6H)-one 
• 1044872-25-4 C₃₁H₃₄N₂O₅ 
• 1044872-53-8 7-(4-benzyloxy-3,5-dimethyl-phenyl)-2,4-diisopropoxy-6H-[1,6]naphthyridin-5-one 
• 1044871-97-7 C₂₃H₂₀N₂O₂ 

Relevant articles and documents

Copper-catalyzed cyanations of aromatic bromides with benzoyl cyanide

Aromatic nitriles were synthesized through copper-catalyzed cyanations of aromatic bromides using benzoyl cyanide as the cyanide source. A series of functional groups were tolerated under the reaction conditions to provide the products in good yields. Moreover, this protocol avoids using of highly toxic alkali cyanides and expensive palladium catalysts.

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of cancer, including NUT midline carcinoma, Burkitt's Lymphoma, Acute Myelogenous Leukemia, and Multiple Myeloma; autoimmune or inflammatory diseases or conditions, and sepsis.

COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotei? A-I (ApoA-l), and their use for the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.